Newsletter
|
Hi, it’s Elizabeth here with this month’s Co-Founder’s Corner.
In 2025, Colorado will launch its Natural Medicine Program, a significant milestone in psychedelic therapy and a major step towards its mass adoption.
Of course, Colorado isn’t the first state to run a psilocybin program; Fluence was heavily involved in Oregon’s pioneering program, which launched in 2023. However, while Oregon’s approach was groundbreaking, Colorado's model promises a more impactful path for psychedelic therapy.
Colorado’s Clinical Facilitator License creates a distinct pathway for licensed psychotherapists. This distinguishes clinical mental health providers from those with other backgrounds and ensures that qualified clinical facilitators are available to treat clients with specific clinical conditions such as depression, addiction, or PTSD.
The training required to gain a clinical facilitator license is reassuringly substantial, reflects the complexity and importance of this work, and ensures that facilitators will be well-equipped to integrate psilocybin therapy safely and effectively.
Building on this commitment to quality and accessibility, the Colorado regulations allow non-residents to obtain clinical facilitator licenses. This inclusive policy broadens the pool of qualified facilitators and will help foster a diverse range of experience and expertise.
Colorado also differs from Oregon because it covers natural medicines as a broad category. However, there is an initial focus on psilocybin, which aligns with promising research from institutions like Johns Hopkins and NYU. This evidence-based approach lends credibility to the program and offers real promise to those living with conditions such as depression, anxiety, and PTSD.
I am very excited about this program and its potential impact on our industry. With thoughtful regulation, comprehensive training, and ongoing research, this program could transform mental health care in Colorado and beyond, offering hope for those struggling with mental health challenges.
If you’re a mental health provider, now is the time to explore the steps needed to enhance your practice before the 2025 launch. Our blog, An Introduction to Psilocybin Therapy in the United States, is a great place to start, and explains the Licensed Clinical Facilitator role in more detail.
Thanks for reading!
Elizabeth Nielson, Fluence Co-Founder
Have you ever wondered what really happens during a psilocybin session? Join our exclusive webinar, which pulls back the curtain on this transformative experience.
Our expert facilitator, Kayli Howard, will join Fluence co-founder Elizabeth Nielson to share her firsthand insights, revealing the intricate process of guiding participants through psychedelic journeys.
From preparation to integration, you'll gain a deeper understanding of the profound impact these sessions can have on mental health and personal growth.
October 29 | 3pm Eastern
The webinar will be hosted on Zoom, and following the discussion, we will hold a Q&A session.
Join our upcoming Open House event, where Admissions Director Dr. Alex Camargo will explore our core Psychedelic Therapy Integration (PTI) course.
Learn what PTI offers practitioners and how it can lead to professional certificates in Ketamine-assisted Psychotherapy, Psychedelic Harm Reduction and Integration Therapy, or Psilocybin Clinical Facilitation.
October 9 | 12pm Eastern
Core Certification Course
Start your psychedelic therapy certificate:
Psychedelic Therapy and Integration (PTI)
October 30 – December 11, 2024
Psychedelic Therapy and Integration (PTI)
November 4 – December 9, 2024
Advanced Certification Courses
After completion of the core course, advance to these courses:
Advanced Ketamine-Assisted Psychotherapy
January 28 – April 15, 2025
Advanced Psychedelic Integration
January 31 – April 18, 2025
Our live courses consist of smaller classes that dive deeper into particular topics. They are great for those looking to earn continuing education credit. Fluence is approved by APA, ASWB, and NYSED to offer CE for Psychologists, Social Workers, and LMHCs.
Reading and Study Groups
Psychedelic Psychopharmacology
An in-depth look at the pharmacodynamics, pharmacokinetics, pharmacogenomics, and neuroscience of psychedelics.
January 6 – March 31, 2025
Trainer: Kelan Thomas, PharmD
Clinical Consultation Groups
Internal Family Systems & Psychedelics
Discuss psychedelic preparation, dosing, and integration work within the discourse of Internal Family Systems.
November 4 – December 9, 2024
Trainer: Candace Oglesby, LCPC
Psychedelic Medicine Has a Therapy Problem. In this article in The Atlantic, Jonathan Lambert looks at why there needs to be more research on pairing therapy with psychedelic drugs.
International Support for Psychedelics: this Sermo Barometer finds 94% of global mental healthcare professionals are open to integrating psychedelic treatments to their practices if legalized.
Colorado's Approach to Psychedelic-Assisted Therapy. As Colorado prepares to roll out its psychedelic therapy program in 2025, the state is charting a course that could revolutionize mental health care.
